Istitu to R egina E le n a for C a n ce r R esearch , R om e * Scripps Clinic an d R esearch F o u n d a tio n . La Jolla + Istitu to N azionale T u m o ri. G en o v a Z . N aturforsch. 41c, 6 6 8 -6 7 0 (1986); received O c to b e r 14/N ovem ber 18, 1985 T h re e im m une se ra , raised in rab b its against synthetic p e p tid e s c o rre sp o n d in g in seq u en ce to p re d e te rm in e d re gions o f the H L A -D Q h istocom patibility antigens, w ere teste d for th eir ability to recognize phenotypically distinct hu m an lym phoblastoid cell lines.
The extensive use of synthetic peptides as im munogens has revealed their ability to induce anti bodies that bind to almost any exposed region of a protein [1, 2] .
Those antipeptide antibodies, because of their pre determ ined sequence specificity, might also offer a good tool for the selective recognition of closely re lated structures, such as the products of allelic genes. It was recently reported that a synthetic peptide, whose sequence corresponds to the region 61-83 of H L A -B 7 heavy chain, is able to induce rabbit anti bodies that specifically recognize the H LA -B7 anti gen, and do not react with membrane glycoproteins from cell lines bearing different HLA-B specificities [3] . This selective recognition might be a quite rare event; crossreactions seem to occur quite often be tween antipeptide antibodies and related or even not related antigens: it has been reported that antisera raised in a rabbit against a 14-residue fragment from a variable region of H L A -D R 2 glycoproteins (13-chain, pos. 61-73) are not able to discriminate LG-2 The three peptides, sharing from 11 to 12 of the 17 amino acid residues (Table I) , were conjugated to a carrier protein by the aid of MBS [5] , and injected into NZW rabbits. A fter a first immunization with 200 ng of complex in com plete Freund's adjuvant, rabbits received bimonthly intracutaneous injections of 100 |ig of complex in incomplete adjuvant. Blood samples were collected after two months, and the immune sera recovered by centrifugation. 
The antipeptide antibodies were first tested in ELISA in their ability to recognize the immunogen ( Fig. 1) , then against the two other "parent" pep tides. Antiserum 203 (anti-B) reacted extensively also with peptide C, and antiserum 207 (anti-C) with peptide B. In contrast, only slight crossreaction (~ 10%) was observed betw een antiserum 202 (anti-A) and peptides B and C, and peptide A was very scarsely recognized by antisera 203 and 207.
The antipeptide antibodies were then assayed against different lymphoblastoid cell lines with known phenotypes. For this test, in order to minimize nonspecific binding of IgG to cells and heavy background, the F (a b ') 2 fragments of each affinity-purified antibody were used instead of the immune sera.
The test was carried out in duplicates as previously described [6] . The cells (5 x 104 in 50 |^1 PBS) were placed in flatbottom 96-wells plates, and dried at 37 °C for 10 hours under gentle air stream. The F (ab')2 fragments were pretreated with protein ASepharose, and used at a concentration of 0.03 mg/ ml. The F (ab') 2 fragment of preimmune rabbit IgG was simultaneously tested as a control. In any case, the binding of the antipeptide anti bodies to the cells is poor, and seldom exceeds 50% of the unspecific binding shown by preim m une sera, when evaluated by ELISA . The use of the F (ab') 2 fragments lowers substantially the background activi ty, but this technique requires additional antibody purification, enzymatic digestion, and isolation of the fragments.
Dilution' 1
The specificities could be improved by absorption and immunodepletion of the antipeptide antibodies by Sepharose-bound peptides mimicking the same region of other H LA -D Q alloantigens. A nother pos sibility is the selection, as immunogens, of shorter.
T able II. R elative reactivity o f a n tip e p tid e a n tibody F ( a b ' ) 2 fragm ents w ith p h enotypically distinct cell lines. T he test was carried on using 50 jj.1 o f F (a b ' ) 2 p re p ara tio n s a t a co n cen tratio n o f 0.03 m g/m l. T h e last step o f th e E L IS A assay (p e ro x id a se -su b stra te re a c tio n ) w as allow ed to p ro c ee d for 5 m inutes only, in o rd e r to have a b so rb an c e at 492 nm not higher th an 1.9. T he a b so rb an ce given by p re im m u n e ra b b it IgG F (a b ' ) 2 fragm ent on each cell line w as su b tra cted . F o r each a n tib o d y , the cell line p resen tin g the hig h est b inding w as given the value 1 0 0 . more representative peptides having unique amino acid sequences, and low homology with related anti gens. Finally, the production of monoclonal anti bodies, directed against a single suitable epitope.
